Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Research and Practice in Thrombosis and Haemostasis|October 6, 2025
Emicizumab utilization, safety, and outcomes in people with severe hemophilia and no inhibitors: 3-year follow-up. A report from the UK Haemophilia Centre Doctors' OrganisationCaroline Wall, Hua Xiang, Ben Palmer, et al.Blood|April 21, 2007
Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIVSarah C Darby, Sau Wan Kan, Rosemary J Spooner, et al.Journal of Thrombosis and Haemostasis : JTH|December 17, 2020
Establishment of a framework for assessing mortality in persons with congenital hemophilia A and its application to an adverse event reporting databaseSteven W Pipe, Rebecca Kruse-Jarres, Johnny N Mahlangu, et al.Journal of Thrombosis and Haemostasis : JTH|July 23, 2025
Impaired tolerance in the International Immune Tolerance Induction study due to the presence of very low-titer inhibitorsLars L F G Valke, Charles R M Hay, Donna M DiMichele, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|February 22, 2023
Emicizumab prophylaxis in haemophilia A with inhibitors: Three years follow-up from the UK Haemophilia Centre Doctors' Organisation (UKHCDO)Caroline Wall, Hua Xiang, Ben Palmer, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|May 9, 2019
Recombinant factor VIII products and inhibitor development in previously untreated patients with severe haemophilia A: Combined analysis of three studiesPeter Volkers, Kay-Martin Hanschmann, Thierry Calvez, et al.Thrombosis and Haemostasis|April 17, 2015
Inhibitors in nonsevere haemophilia A: outcome and eradication strategiesAlice S van Velzen, Corien L Eckhardt, Daniel P Hart, et al.Thrombosis and Haemostasis|May 6, 2020
A Novel, Enriched Population Pharmacokinetic Model for Recombinant Factor VIII-Fc Fusion Protein Concentrate in Hemophilia A PatientsLaura H Bukkems, Jessica M Heijdra, Mary Mathias, et al.Blood|August 9, 2013
Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia ACorien L Eckhardt, Alice S van Velzen, Marjolein Peters, et al.Pageof 3